Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPAIR-CS
NCT06660732Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of rilonacept in cardiac sarcoidosis (CS), sponsored by Mayo Clinic. Started Mar 2025; status: recruiting.
02
Drugs
rilonacept
03
Conditions
cardiac sarcoidosis (CS)
Beyond the preview
Go deeper on NCT06660732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06660732.